UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia

Oncogene, 2007-05, Vol.26 (25), p.3644-3653

2007

Volltextzugriff (PDF)

The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

Leukemia, 2016-04, Vol.30 (4), p.789-799

2016

Volltextzugriff (PDF)

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

The Journal of clinical investigation, 1995-12, Vol.96 (6), p.2578-2582

1995

Volltextzugriff (PDF)

A SINGLE‐CENTER RETROSPECTIVE ANALYSIS OF THE TOXICITY OF HIGH‐DOSE METHOTREXATE (HDMTX) ADMINISTERED ON THE FIRST DAY OF (R)CHOP IN AGGRESSIVE NONHODGKIN LYMPHOMAS (ANHLS)

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment

Current hematologic malignancy reports, 2015-12, Vol.10 (4), p.456-467

2015

Volltextzugriff (PDF)

PRMT5 INHIBITION RESTARTS A PRO‐APOPTOTIC PROGRAM AND CREATES VULNERABILITY TO COMBINATION TREATMENT WITH BCL‐2 INHIBITOR VENETOCLAX IN MANTLE CELL LYMPHOMA

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1250: EU‐SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1135-1136

2022

Volltextzugriff (PDF)

P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN‐BARR VIRUS‐DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU‐PBL‐SCID MODEL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1129-1130

2022

Volltextzugriff (PDF)

EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease

Virology (New York, N.Y.), 2006-03, Vol.346 (1), p.205-218

2006

Volltextzugriff (PDF)

Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: Implications for chronic fatigue syndrome and cancer

Brain, behavior, and immunity, 2005-03, Vol.19 (2), p.91-103

2005

Volltextzugriff (PDF)

Low-Dose Interleukin 2 Prevents the Development of Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disease in scid/scid Mice Reconstituted i.p. with EBV-Seropositive Human Peripheral Blood Lymphocytes

Proceedings of the National Academy of Sciences - PNAS, 1994-06, Vol.91 (12), p.5577-5581

1994

Volltextzugriff (PDF)

Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma

Cancer research (Chicago, Ill.), 2003-03, Vol.63 (5), p.965-971

2003

Volltextzugriff (PDF)

Lymphomagenesis in the SCID-hu Mouse Involves Abundant Production of Human Interleukin-10

Blood, 1995-02, Vol.85 (4), p.1063-1074

1995

Volltextzugriff (PDF)

The c-Kit Ligand Suppresses Apoptosis of Human Natural Killer Cells Through the Upregulation of bcl-2

Proceedings of the National Academy of Sciences - PNAS, 1994-08, Vol.91 (16), p.7553-7557

1994

Volltextzugriff (PDF)

Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus–Positive Lymphoproliferative Disorder

JNCI : Journal of the National Cancer Institute, 2004-10, Vol.96 (19), p.1447-1457

2004

Volltextzugriff (PDF)

Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome

Blood, 1997-09, Vol.90 (5), p.1737-1746

1997

Volltextzugriff (PDF)

Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: Results from a prospective multicentric study in Italy

European journal of obstetrics & gynecology and reproductive biology, 2009-04, Vol.143 (2), p.103-106

2009

Volltextzugriff (PDF)

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

The Journal of clinical investigation, 2001-09, Vol.108 (6), p.887-894

2001

Volltextzugriff (PDF)

Endogenous CD8+ T Cell Expansion During Regression of Monoclonal EBV-Associated Posttransplant Lymphoproliferative Disorder

The Journal of immunology (1950), 1999-07, Vol.163 (1), p.500-506

1999

Volltextzugriff (PDF)

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies

The Journal of clinical investigation, 1998-03, Vol.101 (6), p.1373-1378

1998

Volltextzugriff (PDF)

The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor Gene

Molecular and Cellular Biology, 2005-09, Vol.25 (18), p.7953-7965

2005

Volltextzugriff (PDF)

Alemtuzumab (campath-1H) in the treatment of chronic lymphocytic leukemia: Antibody therapies for cancer

Oncogene, 2007, Vol.26 (25), p.3644-3653

2007

Volltextzugriff (PDF)

Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: A preclinical and phase I study

Clinical cancer research, 2004-09, Vol.10 (18), p.6101-6110

2004

Volltextzugriff (PDF)

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

The Journal of clinical investigation, 2001-09, Vol.108 (6), p.887-894

Baiocchi, R. A.

2001

Volltextzugriff (PDF)

Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-α–refractory adult T-cell leukemia

Blood, 2005-11, Vol.106 (10), p.3380-3382

2005

Volltextzugriff (PDF)

1 – 25 von 576

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(487)
Mit Volltextzugriff
(468)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia

The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

A SINGLE‐CENTER RETROSPECTIVE ANALYSIS OF THE TOXICITY OF HIGH‐DOSE METHOTREXATE (HDMTX) ADMINISTERED ON THE FIRST DAY OF (R)CHOP IN AGGRESSIVE NONHODGKIN LYMPHOMAS (ANHLS)

The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment

PRMT5 INHIBITION RESTARTS A PRO‐APOPTOTIC PROGRAM AND CREATES VULNERABILITY TO COMBINATION TREATMENT WITH BCL‐2 INHIBITOR VENETOCLAX IN MANTLE CELL LYMPHOMA

P1250: EU‐SOX11CCND1: A NOVEL IMMUNOCOMPETENT MURINE MODEL OF MANTLE CELL LYMPHOMA

P1244: ROLE OF SELECT T HELPER CELL MONONUCLEAR CELL SUBSETS PROMOTING EPSTEIN‐BARR VIRUS‐DRIVEN LYMPHOPROLIFERATIVE DISEASE IN THE HU‐PBL‐SCID MODEL

EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease

Stress-associated changes in the steady-state expression of latent Epstein–Barr virus: Implications for chronic fatigue syndrome and cancer

Low-Dose Interleukin 2 Prevents the Development of Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disease in scid/scid Mice Reconstituted i.p. with EBV-Seropositive Human Peripheral Blood Lymphocytes

Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma

Lymphomagenesis in the SCID-hu Mouse Involves Abundant Production of Human Interleukin-10

The c-Kit Ligand Suppresses Apoptosis of Human Natural Killer Cells Through the Upregulation of bcl-2

Selective Efficacy of Depsipeptide in a Xenograft Model of Epstein-Barr Virus–Positive Lymphoproliferative Disorder

Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome

Determinants of adenomyosis in women who underwent hysterectomy for benign gynecological conditions: Results from a prospective multicentric study in Italy

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

Endogenous CD8+ T Cell Expansion During Regression of Monoclonal EBV-Associated Posttransplant Lymphoproliferative Disorder

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies

The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor Gene

Alemtuzumab (campath-1H) in the treatment of chronic lymphocytic leukemia: Antibody therapies for cancer

Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: A preclinical and phase I study

GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder

Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-α–refractory adult T-cell leukemia

Suchergebnisse filtern